Current issue
About the Journal
Scientific Council
Editorial Board
Regulatory and archival policy
Code of publishing ethics
Publisher
Information about the processing of personal data in relation to cookies and newsletter subscription
Archive
For Authors
For Reviewers
Contact
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Links
Sklep Wydawnictwa SUM
Biblioteka Główna SUM
Śląski Uniwersytet Medyczny w Katowicach
Privacy policy
Accessibility statement
Reviewers
Annals reviewers in 2023
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Review of respiratory physiotherapy methods in patients with cystic fibrosis
1
Zakład Biochemii i Genetyki Medycznej, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach, Polska / Department of Biochemistry and Medical Genetics, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland
2
Szkoła Doktorska, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach, Polska / Doctoral School, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland
Corresponding author
Oktawia Kuna
Zakład Biochemii i Genetyki Medycznej, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach, ul. Medyków 18, 40-752 Katowice
Zakład Biochemii i Genetyki Medycznej, Wydział Nauk o Zdrowiu w Katowicach, Śląski Uniwersytet Medyczny w Katowicach, ul. Medyków 18, 40-752 Katowice
Ann. Acad. Med. Siles. 2023;77:7-16
KEYWORDS
TOPICS
ABSTRACT
Respiratory physiotherapy is an integral part of the therapy of patients with cystic fibrosis. Patients should be rehabilitated regularly and systematically throughout their lives, and should become independent in pulmonary rehabilitation as soon as possible. Knowledge of the methods and principles of pulmonary rehabilitation by physiotherapists will allow the proper selection of respiratory physiotherapy techniques. The aim of the study was to compare pulmonary rehabilitation methods used in cystic fibrosis patients from birth to adolescence.
To achieve the goal, two authors searched the following databases: PubMed, the Cochrane Library and Google Scholar from June 2021 to December 2021. 58 articles were included in the review.
There are few studies confirming the effectiveness of one method over the other, and the discrepancies in the methodology of source works prevent unequivocal conclusions. The selection of techniques should be appropriate to the needs of patients with cystic fibrosis. For this purpose, physiotherapists should broaden their knowledge of the methods of pulmonary rehabilitation confirmed by both practical skills and scientific evidence.
REFERENCES (58)
1.
Brown S.D., White R., Tobin P. Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, and treatment. JAAPA 2017; 30(5): 23–27, doi: 10.1097/01.JAA.0000515540.36581.92.
2.
Elborn J.S. Cystic fibrosis. Lancet 2016; 388(10059): 2519–2531, doi: 10.1016/S0140-6736(16)00576-6.
3.
Flume P.A., Robinson K.A., O’Sullivan B.P., Finder J.D., Vender R.L., Willey-Courand D.B. i wsp. Cystic fibrosis pulmonary guidelines: Airway clearance therapies. Respir. Care 2009; 54(4): 522–537.
4.
Daniels T. Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults. J. Multidiscip. Healthc. 2010; 3: 201–212, doi: 10.2147/JMDH.S8878.
5.
Rand S., Hill L., Prasad S.A. Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes. Paediatr. Respir. Rev. 2013; 14(4): 263–269, doi: 10.1016/j.prrv.2012.08.006.
6.
Holland A.E., Button B.M. Physiotherapy for cystic fibrosis in Australia: Knowledge and acceptance of the Consensus Statement recommendations. Respirology 2013; 18(4): 652–656, doi: 10.1111/resp.12032.
7.
Button B.M., Wilson C., Dentice R., Cox N.S., Middleton A., Tannenbaum E. i wsp. Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline. Respirology 2016; 21(4): 656–667, doi: 10.1111/resp.12764.
8.
Stoltz D.A., Meyerholz D.K., Welsh M.J. Origins of cystic fibrosis lung disease. N. Engl. J. Med. 2015; 372(4): 363, doi: 10.1056/NEJMra1300109.
9.
Wilson L.M., Morrison L., Robinson K.A. Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews. Cochrane Database Syst. Rev. 2019; 1(1): CD011231, doi: 10.1002/14651858.CD011231.
10.
Walkowiak J., Pogorzelski A., Sands D., Skoprupa W., Milanowski A., Nowakowska A. i wsp. Zasady rozpoznawania i leczenia mukowiscydozy: zalecenia Polskiego Towarzystwa Mukowiscydozy 2009 Poznań – Warszawa – Rzeszów. Stand. Med. Pediatr. 2009; 6: 352–378.
11.
Warnock L., Gates A., van der Schans C.P. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst. Rev. 2013; (9): CD001401, doi: 10.1002/14651858.CD001401.pub2.
12.
Warnock L., Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst. Rev. 2015; 2015(12): CD001401, doi: 10.1002/14651858.CD001401.pub3.
13.
Physiotherapy for people with cystic fibrosis: from infant to adult [pdf]. 6th ed. International Physiotherapy Group for Cystic Fibrosis 2019. Dostępny w internecie: https://www.ecfs.eu/sites/defa... [dostęp: 17.01.2023].
14.
Rowbotham N.J., Daniels T.E. Airway clearance and exercise for people with cystic fibrosis: Balancing longevity with life. Pediatr. Pulmonol. 2022; 57(S1): S50–S59, doi: 10.1002/ppul.25734.
15.
Button B.M., Heine R.G., Catto-Smith A.G., Phelan P.D., Olinsky A. Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis. Arch. Dis. Child. 1997; 76(2): 148–150, doi: 10.1136/adc.76.2.148.
16.
Giles D.R., Wagener J.S., Accurso F.J., Butler-Simon N. Short-term effects of postural drainage with clapping vs autogenic drainage on oxygen saturation and sputum recovery in patients with cystic fibrosis. Chest 1995; 108(4): 952–954, doi: 10.1378/chest.108.4.952.
17.
Tyrrell J.C., Hiller E.J., Martin J. Face mask physiotherapy in cystic fibrosis. Arch. Dis. Child. 1986; 61(6): 598–600, doi: 10.1136/adc.61.6.598.
18.
Main E., Prasad A., van der Schans C.P. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst. Rev. 2005; 2005(1): CD002011, doi: 10.1002/14651858.CD002011.pub2.
19.
Button B., Herbert R., Maher C. Positive expiratory pressure therapy better maintains pulmonary function than postural drainage and percussion in patients with cystic fibrosis. Aust. J. Physiother. 1998; 44(4): 285–286.
20.
Mckoy N.A., Wilson L.M., Saldanha I.J., Odelola O.A., Robinson K.A. Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst. Rev. 2016; 7(7): CD007862, doi: 10.1002/14651858.CD007862.pub4.
21.
Pryor J.A., Tannenbaum E., Scott S.F., Burgess J., Cramer D., Gyi K. i wsp. Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis. J. Cyst. Fibros. 2010; 9(3): 187–192, doi: 10.1016/j.jcf.2010.01.004.
22.
Miller S., Hall D.O., Clayton C.B., Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995; 50(2): 165–169, doi: 10.1136/thx.50.2.165.
23.
Davidson A.G.F., McIlwaine P.M., Wong T.K., Nakielna E.M., Pirie G.E. Physiotherapy in cystic fibrosis: A comparative trial of positive expiratory pressure, autogenic drainage and conventional percussion and drainage techniques. Pediatr. Pulmonol. 1988; 5(Suppl 2): 137.
24.
McIlwaine M., Wong L.T., Chilvers M., Davidson G.F. Long-term comparative trial of two different physiotherapy techniques; postural drainage with percussion and autogenic drainage, in the treatment of cystic fibrosis. Pediatr. Pulmonol. 2010; 45(11): 1064–1069, doi: 10.1002/ppul.21247.
25.
McCormack P., Burnham P., Southern K.W. Autogenic drainage for airway clearance in cystic fibrosis. Cochrane Database Syst. Rev. 2017; 10(10): CD009595, doi: 10.1002/14651858.CD009595.pub2.
26.
Walicka-Serzysko K., Postek M., Jeneralska N., Cichocka A., Milczewska J., Sands D. The effects of the addition of a new airway clearance device to chest physiotherapy in children with cystic fibrosis pulmonary exacerbations. J. Mother Child 2021; 24(3): 16–24, doi: 10.34763/jmotherandchild.20202403.2013.d-20-00008.
27.
McIlwaine M., Button B., Dwan K. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst. Rev. 2015; (6): CD003147, doi: 10.1002/14651858.CD003147.pub4.
28.
McIlwaine M., Button B., Nevitt S.J. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst. Rev. 2019; 2019(11): CD003147, doi: 10.1002/14651858.CD003147.pub5.
29.
McIlwaine M.P., Alarie N., Davidson G.F., Lands L.C., Ratjen F., Milner R. i wsp. Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax 2013; 68(8): 746–751, doi: 10.1136/thoraxjnl-2012-202915.
30.
McIlwaine P.M., Wong L.T., Peacock D., Davidson A.G. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J. Pediatr. 2001; 138(6): 845–850, doi: 10.1067/mpd.2001.114017.
31.
Cabillic M., Gouilly P., Reychler G. Manual airway clearance techniques in adults and adolescents: What level of evidence? [Article in French] Rev. Mal. Respir. 2018; 35(5): 495–520, doi: 10.1016/j.rmr.2015.12.004.
32.
Van Fleet H., Dunn D.K., McNinch N.L., Volsko T.A. Evaluation of functional characteristics of 4 oscillatory positive pressure devices in a simulated cystic fibrosis model. Respir. Care 2017; 62(4): 451–458, doi: 10.4187/respcare.04570.
33.
Demchuk A.M., Chatburn R.L. Performance characteristics of positive expiratory pressure devices. Respir. Care 2021; 66(3): 482–493, doi: 10.4187/respcare.08150.
34.
Ward N., Ward B., Stiller K., Kenyon A., Holland A.E. Development of a device to measure adherence and pressure characteristics of positive expiratory pressure therapies used by adults with cystic fibrosis. Physiother. Theory Pract. 2022; 38(10): 1469–1477, doi: 10.1080/09593985.2020.1858465.
35.
Franks L.J., Walsh J.R., Hall K., Jacuinde G., Yerkovich S., Morris N.R. Comparing the performance characteristics of different positive expiratory pressure devices. Respir. Care 2019; 64(4): 434–444, doi: 10.4187/respcare.06410.
36.
Poncin W., Reychler G., Liistro M., Liistro G. Comparison of 6 oscillatory positive expiratory pressure devices during active expiratory flow. Respir. Care 2020; 65(4): 492–499, doi: 10.4187/respcare.07271.
37.
Morrison L., Innes S. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst. Rev. 2017; 5(5): CD006842, doi: 10.1002/14651858.CD006842.pub4.
38.
Phillips G.E., Pike S.E., Jaffé A., Bush A. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatr. Pulmonol. 2004; 37(1): 71–75, doi: 10.1002/ppul.10358.
39.
Osman L.P., Roughton M., Hodson M.E., Pryor J.A. Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax 2010; 65(3): 196–200, doi: 10.1136/thx.2008.111492.
40.
Elkins M., Dentice R. Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst. Rev. 2016; 2016(12): CD008816, doi: 10.1002/14651858.CD008816.pub3.
41.
Dentice R., Elkins M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst. Rev. 2018; 11(11): CD007923, doi: 10.1002/14651858.CD007923.pub5.
42.
van der Giessen L.J., de Jongste J.C., Gosselink R., Hop W.C., Tiddens H.A. RhDNase before airway clearance therapy improves airway patency in children with CF. Pediatr. Pulmonol. 2007; 42(7): 624–630, doi: 10.1002/ppul.20636.
43.
Anderson P., Morton J. Evaluation of two different timings of Pulmozyme nebulisation in relation to chest physiotherapy in children with Cystic Fibrosis. J. Cyst. Fibros. 2009; 8(Suppl. 2): S74, doi: 10.1016/S1569-1993(09)60294-0.
44.
van der Giessen L.J., Gosselink R., Hop W.C., Tiddens H.A. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up? Eur. Respir. J. 2007; 30(4): 763–768, doi: 10.1183/09031936.00031107.
45.
Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R. i wsp. Interpretative strategies for lung function tests. Eur. Respir. J. 2005; 26(5): 948–968, doi: 10.1183/09031936.05.00035205.
46.
Cooper P.J., Robertson C.F., Hudson I.L., Phelan P.D. Variability of pulmonary function tests in cystic fibrosis. Pediatr. Pulmonol. 1990; 8(1): 16–22, doi: 10.1002/ppul.1950080107.
47.
Moola F.J., Garcia E., Huynh E., Henry L., Penfound S., Consunji-Araneta R. i wsp. Physical activity counseling for children with cystic fibrosis. Respir. Care 2017; 62(11): 1466–1473, doi: 10.4187/respcare.05009.
48.
Warburton D.E., Nicol C.W., Bredin S.S. Health benefits of physical activity: the evidence. CMAJ 2006; 174(6): 801–809, doi: 10.1503/cmaj.051351.
49.
Plewa M., Markiewicz A. Aktywność fizyczna w profilaktyce i leczeniu otyłości. Endokrynol. Otył. Zab. Przem. Mat. 2006; 2(1): 30–37.
50.
Roberts C.K., Barnard R.J. Effects of exercise and diet on chronic disease. J. Appl. Physiol. (1985) 2005; 98(1): 3–30, doi: 10.1152/japplphysiol.00852.2004.
51.
Blair S.N., Cheng Y., Holder J.S. Is physical activity or physical fitness more important in defining health benefits? Med. Sci. Sports Exerc. 2001; 33(6 Suppl): S379–S399, doi: 10.1097/00005768-200106001-00007.
52.
Barengo N.C., Hu G., Kastarinen M., Lakka T.A., Pekkarinen H., Nissinen A. i wsp. Low physical activity as a predictor for antihypertensive drug treatment in 25–64-year-old populations in eastern and south-western Finland. J. Hypertens. 2005; 23(2): 293–299, doi: 10.1097/00004872-200502000-00011.
53.
Burtin C., Hebestreit H. Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: Exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respiration 2015; 89(3): 181–189, doi: 10.1159/000375170.
54.
Cox N.S., Holland A.E. Current perspectives of physical activity in cystic fibrosis. Expert Rev. Respir. Med. 2019; 13(1): 13–22, doi: 10.1080/17476348.2019.1552833.
55.
Gruber W., Stehling F., Olivier M., Dillenhoefer S., Koerner-Rettberg C., Sutharsan S. i wsp. Effects of a long-term exercise program on motor performance in children and adolescents with CF. Pediatr. Pulmonol. 2020; 55(12): 3371–3380, doi: 10.1002/ppul.25064.
56.
Del Corral T., Cebrià I Iranzo M.À., López-de-Uralde-Villanueva I., Martínez-Alejos R., Blanco I., Vilaró J. Effectiveness of a Home-Based Active Video Game Programme in Young Cystic Fibrosis Patients. Respiration 2018; 95(2): 87–97, doi: 10.1159/000481264.
57.
Carbonera R.P., Vendrusculo F.M., Donadio M.V. Physiological responses during exercise with video games in patients with cystic fibrosis: A systematic review. Respir. Med. 2016; 119: 63–69, doi: 10.1016/j.rmed.2016.08.011.
58.
Radtke T., Nevitt S.J., Hebestreit H., Kriemler S. Physical exercise training for cystic fibrosis. Cochrane Database Syst. Rev. 2017; 11(11): CD002768, doi: 10.1002/14651858.CD002768.pub4.
Share
RELATED ARTICLE
| eISSN: | 1734-025X |
The Medical University of Silesia in Katowice, as the Operator of the annales.sum.edu.pl website, processes personal data collected when visiting the website. The function of obtaining information about Users and their behavior is carried out by voluntarily entered information in forms, saving cookies in end devices, as well as by collecting web server logs, which are in the possession of the website Operator. Data, including cookies, are used to provide services in accordance with the Privacy policy.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
